vs
Howard Hughes Holdings Inc.（HHH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Howard Hughes Holdings Inc.的季度营收约是Royalty Pharma plc的1.0倍（$624.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 1.0%，领先33.5%），Royalty Pharma plc同比增速更快（4.8% vs -33.2%），过去两年Howard Hughes Holdings Inc.的营收复合增速更高（91.0% vs 4.6%）
霍华德·休斯控股有限公司是总部位于美国得克萨斯州伍德兰兹的房地产开发与管理企业，前身为霍华德·休斯公司，2010年从通用增长物业（GGP）分拆独立成立，核心资产集中于多个整体规划社区项目，公司名称源自最初的霍华德·休斯公司，后者曾开发内华达州萨姆林规划社区，后成为GGP子公司。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HHH vs RPRX — 直观对比
营收规模更大
HHH
是对方的1.0倍
$622.0M
营收增速更快
RPRX
高出38.0%
-33.2%
净利率更高
RPRX
高出33.5%
1.0%
两年增速更快
HHH
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $624.4M | $622.0M |
| 净利润 | $6.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 4.2% | 62.4% |
| 净利率 | 1.0% | 34.4% |
| 营收同比 | -33.2% | 4.8% |
| 净利润同比 | -96.2% | 2.9% |
| 每股收益（稀释后） | $0.20 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HHHRPRX
| Q4 25 | $624.4M | $622.0M | ||
| Q3 25 | $390.2M | $609.3M | ||
| Q2 25 | $260.9M | $578.7M | ||
| Q1 25 | $199.3M | $568.2M | ||
| Q4 24 | $935.0M | $593.6M | ||
| Q3 24 | $327.1M | $564.7M | ||
| Q2 24 | $317.4M | $537.3M | ||
| Q1 24 | $171.1M | $568.0M |
净利润HHHRPRX
| Q4 25 | $6.0M | $214.2M | ||
| Q3 25 | $119.5M | $288.2M | ||
| Q2 25 | $-12.1M | $30.2M | ||
| Q1 25 | $10.5M | $238.3M | ||
| Q4 24 | $156.3M | $208.2M | ||
| Q3 24 | $72.8M | $544.0M | ||
| Q2 24 | $21.1M | $102.0M | ||
| Q1 24 | $-52.5M | $4.8M |
营业利润率HHHRPRX
| Q4 25 | 4.2% | 62.4% | ||
| Q3 25 | 48.6% | 70.1% | ||
| Q2 25 | 26.0% | 36.3% | ||
| Q1 25 | 24.0% | 94.0% | ||
| Q4 24 | 33.5% | 60.9% | ||
| Q3 24 | 60.6% | — | ||
| Q2 24 | 20.4% | 50.2% | ||
| Q1 24 | -9.8% | -13.0% |
净利率HHHRPRX
| Q4 25 | 1.0% | 34.4% | ||
| Q3 25 | 30.6% | 47.3% | ||
| Q2 25 | -4.7% | 5.2% | ||
| Q1 25 | 5.3% | 41.9% | ||
| Q4 24 | 16.7% | 35.1% | ||
| Q3 24 | 22.2% | 96.3% | ||
| Q2 24 | 6.6% | 19.0% | ||
| Q1 24 | -30.7% | 0.8% |
每股收益（稀释后）HHHRPRX
| Q4 25 | $0.20 | $0.49 | ||
| Q3 25 | $2.02 | $0.67 | ||
| Q2 25 | $-0.22 | $0.07 | ||
| Q1 25 | $0.21 | $0.55 | ||
| Q4 24 | $3.14 | $0.46 | ||
| Q3 24 | $1.46 | $1.21 | ||
| Q2 24 | $0.42 | $0.23 | ||
| Q1 24 | $-1.06 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.5B | $618.7M |
| 总债务越低越好 | $5.1B | $9.0B |
| 股东权益账面价值 | $3.8B | $9.7B |
| 总资产 | $10.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.35× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HHHRPRX
| Q4 25 | $1.5B | $618.7M | ||
| Q3 25 | $1.5B | $938.9M | ||
| Q2 25 | $1.4B | $631.9M | ||
| Q1 25 | $493.7M | $1.1B | ||
| Q4 24 | $596.1M | $929.0M | ||
| Q3 24 | $400.7M | $950.1M | ||
| Q2 24 | $436.8M | $1.8B | ||
| Q1 24 | $462.7M | $843.0M |
总债务HHHRPRX
| Q4 25 | $5.1B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $5.1B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益HHHRPRX
| Q4 25 | $3.8B | $9.7B | ||
| Q3 25 | $3.8B | $9.6B | ||
| Q2 25 | $3.6B | $9.5B | ||
| Q1 25 | $2.8B | $9.8B | ||
| Q4 24 | $2.8B | $10.3B | ||
| Q3 24 | $2.6B | $10.3B | ||
| Q2 24 | $3.0B | $9.8B | ||
| Q1 24 | $2.9B | $9.9B |
总资产HHHRPRX
| Q4 25 | $10.6B | $19.6B | ||
| Q3 25 | $10.7B | $19.3B | ||
| Q2 25 | $10.3B | $18.3B | ||
| Q1 25 | $9.3B | $17.6B | ||
| Q4 24 | $9.2B | $18.2B | ||
| Q3 24 | $9.4B | $18.0B | ||
| Q2 24 | $9.9B | $17.7B | ||
| Q1 24 | $9.6B | $16.1B |
负债/权益比HHHRPRX
| Q4 25 | 1.35× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 1.85× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $360.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $348.6M | — |
| 自由现金流率自由现金流/营收 | 55.8% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 60.04× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $417.6M | — |
8季度趋势，按日历期对齐
经营现金流HHHRPRX
| Q4 25 | $360.3M | $827.1M | ||
| Q3 25 | $149.8M | $702.6M | ||
| Q2 25 | $177.3M | $364.0M | ||
| Q1 25 | $-224.9M | $596.1M | ||
| Q4 24 | $337.1M | $742.5M | ||
| Q3 24 | $248.3M | $703.6M | ||
| Q2 24 | $-17.5M | $658.2M | ||
| Q1 24 | $-171.2M | $664.6M |
自由现金流HHHRPRX
| Q4 25 | $348.6M | — | ||
| Q3 25 | $137.7M | — | ||
| Q2 25 | $169.7M | — | ||
| Q1 25 | $-238.4M | — | ||
| Q4 24 | $317.1M | — | ||
| Q3 24 | $238.7M | — | ||
| Q2 24 | $-25.1M | — | ||
| Q1 24 | $-182.0M | — |
自由现金流率HHHRPRX
| Q4 25 | 55.8% | — | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 65.1% | — | ||
| Q1 25 | -119.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 73.0% | — | ||
| Q2 24 | -7.9% | — | ||
| Q1 24 | -106.4% | — |
资本支出强度HHHRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 6.3% | — |
现金转化率HHHRPRX
| Q4 25 | 60.04× | 3.86× | ||
| Q3 25 | 1.25× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | -21.35× | 2.50× | ||
| Q4 24 | 2.16× | 3.57× | ||
| Q3 24 | 3.41× | 1.29× | ||
| Q2 24 | -0.83× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HHH
| Transferred At Point In Time | $499.8M | 80% |
| Operating Assets Segment | $117.9M | 19% |
| Builder Price Participation | $12.9M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
